Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in South Dakota

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in South Dakota. What South Dakota requires of telehealth prescribers and pharmacies, plus listings with their verification status.

South Dakota at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving South Dakota

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves South Dakota (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in South Dakota

SDCL chapter 34-52 (Telehealth Utilization by Health Care Professionals, enacted in 2019 and amended in 2020 and 2021) defines telehealth to include interactive audio-video, interactive audio with store and forward, store-and-forward technology, and remote patient monitoring, and it defines store-and-forward technology as information stored for asynchronous delivery of care. The professional must be licensed in South Dakota (or be employed by a qualifying facility). SDCL 34-52-3 requires a proper provider-patient relationship, which includes verifying the patient's identity and location, disclosing the provider's credentials, obtaining consent, establishing a diagnosis through acceptable medical practices (history, examination, and any needed testing), discussing treatment options, arranging follow-up, and using technology sufficient to evaluate the condition. SDCL 34-52-5 requires a face-to-face examination by real-time audio and video before diagnosis and treatment whenever a face-to-face encounter would be required for the same service in person. SDCL 34-52-6 bars prescribing a controlled substance solely in response to an internet questionnaire or consult, including by telephone, without a proper relationship; GLP-1 medicines and the peptides in this database are not controlled, so that express bar does not reach them, but 34-52-3 and 34-52-5 still apply. This record classifies asynchronous prescribing as unresolved because the law is ambiguous: store-and-forward is inside the telehealth definition, but no provision says the relationship can be formed that way, and the real-time examination rule in 34-52-5 applies whenever in-person care would call for a face-to-face visit. The law also does not say whether a questionnaire alone can support a prescription for a drug that is not a controlled substance. [2]

Compounded GLP-1 access in South Dakota

South Dakota has not published a state rule that is looser than FDA policy. Because many South Dakota patients use mail order, confirming that the dispensing pharmacy holds a South Dakota nonresident license is the main practical check. [1] [3] [7]

Research use only sellers in South Dakota

SDCL chapter 36-11 reserves dispensing of prescription drugs to licensed pharmacies and pharmacists, so shipping "research use only" injectable peptides to South Dakota consumers is not a licensed pharmacy activity. [3] [8]

How to check a telehealth provider in South Dakota

  1. Confirm the prescriber is licensed or registered to treat patients located in South Dakota; the telehealth rules above explain what South Dakota requires. [2]
  2. Ask which pharmacy will fill the prescription and check it in the South Dakota Board of Pharmacy (South Dakota Department of Health) license lookup. [1] [3] [4] [5] [6]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in South Dakota. [3] [8]

Common questions in South Dakota

Can I get a GLP-1 prescription in South Dakota through telehealth?

Yes, from a provider licensed in South Dakota (or employed by a facility listed in SDCL 34-52-2) who first establishes a proper provider-patient relationship under SDCL 34-52-3. That relationship requires identity verification, consent, a diagnosis based on examination and any needed tests, a discussion of options, and follow-up care. SDCL 34-52-5 also requires a real-time audio and video examination whenever the same care in person would call for a face-to-face visit. [2]

Does South Dakota allow prescribing from an online questionnaire?

South Dakota law does not settle this for drugs that are not controlled substances. SDCL 34-52-6 bars prescribing a controlled substance solely in response to an internet questionnaire or consult, including by telephone, without a proper provider-patient relationship. GLP-1 drugs are not controlled, so that bar does not reach them. SDCL 34-52-3 still requires a proper relationship with a diagnosis reached through acceptable medical practices, and SDCL 34-52-5 requires a real-time audio and video examination whenever the same care in person would call for a face-to-face visit. [2]

Does an out-of-state pharmacy need a South Dakota license to ship me compounded peptides?

Yes. SDCL 36-11-19.2 and 36-11-19.3 define nonresident pharmacies and require them to be licensed by the South Dakota Board of Pharmacy, with proof of good standing in their home state. Check the Board's license lookup before ordering. [1] [3] [4]

All peptide legal questions for South Dakota

Sources

  1. [1]South Dakota Board of Pharmacy (South Dakota Department of Health)
  2. [2]South Dakota Codified Laws chapter 34-52, Telehealth utilization by health care professionals
  3. [3]South Dakota Codified Laws chapter 36-11, Pharmacists and pharmacies (including nonresident pharmacy licensure, 36-11-19.2 and 36-11-19.3)
  4. [4]South Dakota Codified Laws 36-11-19.3, Nonresident pharmacy licensure
  5. [5]Administrative Rules of South Dakota chapter 20:51:31, Compounding practices (amended effective September 15, 2025)
  6. [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  7. [7]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  8. [8]21 U.S.C. 331, Prohibited acts